5240 articles
Steve Tilles, Senior Director of Medical Affairs at Aimmune Therapeutics, the first company to gain FDA approval of a peanut allergy treatment, PALFORZI...
Susan Mitmesser, VP of Science and Technology at Pharmavite, makers of Nature Made vitamins and supplements, discusses a review paper by Pharmavite that...
Daniel Simon discusses the GuardantINFORM™ platform featuring an extensive clinical-genomic liquid biopsy dataset of advanced cancer patients.
Galderma's "Beyond the visible: rosacea and psoriasis of the face" is a global survey involving over 600 patients with facial skin disease (rosacea or p...
Carlos Doti discusses the results from two trials - Ph.2 ACE-CL-001 and Ph.3 ASCEND, that was presented at the virtual edition of the European Hematolog...
Imamu Tomlinson, CEO of Vituity and a practicing emergency physician, discusses his own experience with discrimination as a Black American and how it ha...
Linda Hand, CEO of Prealize, discusses the use of AI and machine learning to pinpoint individuals and populations most likely to have a significant heal...
Cedric Bryant, Ph.D., Chief Science Officer at the American Council on Exercise (ACE) discusses ACE's behavior change research-based philosophy called t...
Roy Herbst, MD, of Yale Cancer Center and Smilow Cancer Hospital, discusses data presented at the American Society of Clinical Oncology (ASCO20) Virtual...
Oswald Peterson, diagnosed in early 2017 with stage 4 non-small cell lung cancer that had spread throughout his body shares his story and talks about th...